Dicamba is a broad-spectrum herbicide that some scientific studies link to cancer and hypothyroidism. In the European Union, dicamba is classified as a category II suspected endocrine disruptor, which means it has the potential to interfere with the body’s hormones and normal functioning. Dicamba caused widespread crop damage to millions of acres of farmland in … Dicamba: concerns about cancer and crop damage
After three stunning courtroom losses in California, the legal battle over the safety of Monsanto’s top-selling Roundup herbicide is headed for the company’s hometown, where corporate officials can be forced to appear on the witness stand, and legal precedence shows a history of anti-corporate judgments. Sharlean Gordon, an cancer-stricken woman in her 50s, is the … Up Next – Trial In Monsanto’s Hometown Set for August After $2 Billion Roundup Cancer Verdict
After several months out of the headlines, lawyers for both sides of the nationwide Roundup cancer litigation are gearing up for overlapping trials in the new year as several more cancer patients seek to blame Monsanto for their diseases. Six trials are currently set to take place starting in January, with one in February, two … Six Monsanto Roundup Cancer Trials Set for January
It’s been nearly five years since international cancer scientists classified a popular weed-killing chemical as probably carcinogenic, news that triggered an explosion of lawsuits brought by cancer patients who blame the former chemical maker Monsanto Co. for their suffering. Tens of thousands of U.S. plaintiffs – some lawyers involved in the litigation say over 100,000 … Stakes are high with two Roundup cancer trials starting amid settlement talks
(UPDATE) – On Sept. 12, the Missouri Supreme Court closed the case, agreeing with plaintiffs’ attorneys that Monsanto’s request for the high court to take up the venue issue was moot. St. Louis Circuit Court Judge Michael Mullen then transferred all plaintiffs except Winston to St. Louis County in a Sept. 13 order.) An October … UPDATED- St. Louis Trial over Monsanto Roundup Cancer Claims in Limbo
Sign up for our newsletter to get our latest stories delivered straight to your inbox.
